EVGN
Price
$0.74
Change
+$0.01 (+1.37%)
Updated
Mar 28, 6:59 PM EST
60 days until earnings call
MNMD
Price
$9.40
Change
-$0.10 (-1.05%)
Updated
Mar 28, 6:59 PM EST
47 days until earnings call
Ad is loading...

Compare trend and price EVGN vs MNMD

Header iconEVGN vs MNMD Comparison
Open Charts EVGN vs MNMDBanner chart's image
Evogene
Price$0.74
Change+$0.01 (+1.37%)
Volume$36.45K
CapitalizationN/A
Mind Medicine (MindMed)
Price$9.40
Change-$0.10 (-1.05%)
Volume$1.24M
CapitalizationN/A
View a ticker or compare two or three
EVGN vs MNMD Comparison Chart

Loading...

EVGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MNMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
EVGN vs. MNMD commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a StrongSell and MNMD is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (EVGN: $0.75 vs. MNMD: $9.40)
Brand notoriety: EVGN and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 30% vs. MNMD: 91%
Market capitalization -- EVGN: $37.86M vs. MNMD: $671.68M
EVGN [@Biotechnology] is valued at $37.86M. MNMD’s [@Biotechnology] market capitalization is $671.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 1 FA rating(s) are green whileMNMD’s FA Score has 0 green FA rating(s).

  • EVGN’s FA Score: 1 green, 4 red.
  • MNMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both EVGN and MNMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 4 TA indicator(s) are bullish while MNMD’s TA Score has 2 bullish TA indicator(s).

  • EVGN’s TA Score: 4 bullish, 6 bearish.
  • MNMD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, EVGN is a better buy in the short-term than MNMD.

Price Growth

EVGN (@Biotechnology) experienced а -4.46% price change this week, while MNMD (@Biotechnology) price change was -3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

EVGN is expected to report earnings on May 28, 2024.

MNMD is expected to report earnings on May 15, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EVGN with price predictions.
OPEN
A.I.dvisor published
a Summary for MNMD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MNMD($672M) has a higher market cap than EVGN($37.9M). MNMD YTD gains are higher at: 156.831 vs. EVGN (-10.714). EVGN has higher annual earnings (EBITDA): -22.27M vs. MNMD (-90.7M). MNMD has more cash in the bank: 99.7M vs. EVGN (37.2M). EVGN has less debt than MNMD: EVGN (11.5M) vs MNMD (14.1M). EVGN has higher revenues than MNMD: EVGN (5.72M) vs MNMD (0).
EVGNMNMDEVGN / MNMD
Capitalization37.9M672M6%
EBITDA-22.27M-90.7M25%
Gain YTD-10.714156.831-7%
P/E RatioN/AN/A-
Revenue5.72M0-
Total Cash37.2M99.7M37%
Total Debt11.5M14.1M82%
FUNDAMENTALS RATINGS
EVGN vs MNMD: Fundamental Ratings
EVGN
MNMD
OUTLOOK RATING
1..100
5483
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5934
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EVGN's Valuation (30) in the Biotechnology industry is in the same range as MNMD (59) in the null industry. This means that EVGN’s stock grew similarly to MNMD’s over the last 12 months.

MNMD's Profit vs Risk Rating (81) in the null industry is in the same range as EVGN (100) in the Biotechnology industry. This means that MNMD’s stock grew similarly to EVGN’s over the last 12 months.

MNMD's SMR Rating (98) in the null industry is in the same range as EVGN (98) in the Biotechnology industry. This means that MNMD’s stock grew similarly to EVGN’s over the last 12 months.

MNMD's Price Growth Rating (34) in the null industry is in the same range as EVGN (59) in the Biotechnology industry. This means that MNMD’s stock grew similarly to EVGN’s over the last 12 months.

MNMD's P/E Growth Rating (100) in the null industry is in the same range as EVGN (100) in the Biotechnology industry. This means that MNMD’s stock grew similarly to EVGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVGNMNMD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
EVGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MNMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WIMVX11.05N/A
N/A
Segall Bryant & Hamill Glb All Cp Inst
MNOZX32.12N/A
N/A
Manning & Napier Overseas Series Z
MDVWX8.16N/A
N/A
Manning & Napier Disciplined Value W
BDOAX9.94-0.01
-0.06%
iShares MSCI Total Intl Idx Inv A
OGLCX82.09-0.09
-0.11%
Invesco Global C

EVGN and

Correlation & Price change

A.I.dvisor tells us that EVGN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
+2.01%
AXON - EVGN
30%
Poorly correlated
-0.98%
FATE - EVGN
29%
Poorly correlated
N/A
ARRY - EVGN
28%
Poorly correlated
-1.26%
BIOR - EVGN
27%
Poorly correlated
-5.30%
FBIOP - EVGN
26%
Poorly correlated
-1.01%
More

MNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNMD has been loosely correlated with QSI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MNMD jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNMD
1D Price
Change %
MNMD100%
-1.05%
QSI - MNMD
46%
Loosely correlated
+4.23%
ATAI - MNMD
42%
Loosely correlated
+10.06%
NTLA - MNMD
42%
Loosely correlated
+1.67%
CRSP - MNMD
41%
Loosely correlated
-2.85%
VCYT - MNMD
40%
Loosely correlated
+1.84%
More